Apyx Medical Corporation - Common Stock (NQ:APYX)

2.550 UNCHANGED

Delayed Quote Updated: 10:02 AM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Apyx Medical Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

Apyx Medical (APYX) Q2 2026 Earnings Call Transcript ↗

August 13, 2026

AYON adoption accelerated 22% as surgeons target GLP-1 weight-loss patients.

Via The Motley Fool

Topics Earnings

Apyx Medical Sees GLP-1 Boom Fueling Demand for Renuvion, AYON Body Contouring ↗

August 11, 2026

Apyx Medical (NASDAQ:APYX) is positioning its Renuvion technology and newly launched AYON Body Contouring System to address growing demand for surgical aesthetic procedures, a trend CEO Charlie Goodwin...

Via MarketBeat

Apyx Medical (NASDAQ:APYX) Shares Dip Despite Q2 Earnings Beat ↗

August 06, 2026

Via Chartmill

Apyx Medical Q2 Earnings Call Highlights ↗

August 06, 2026

Apyx Medical (NASDAQ:APYX) reported second-quarter revenue growth of 22% as sales in its surgical aesthetics business increased, led by adoption of its AYON Body Contouring System, international...

Via MarketBeat

Topics Earnings

APYX MEDICAL CORP (NASDAQ:APYX) Surges After Q1 Beat ↗

May 07, 2026

Via Chartmill

APYX Medical Corp (NASDAQ:APYX) Meets Minervini Trend Template with High-Growth Momentum ↗

March 24, 2026

Via Chartmill

Apyx Medical Corp (NASDAQ:APYX) Reports Q4 Revenue Beat and Narrowed Loss ↗

March 10, 2026

Via Chartmill

What to Know About This Fund's $13.9 Million Exit From a Skyrocketing AI Power Play ↗

May 21, 2026

Babcock & Wilcox delivers energy and emissions control solutions to industrial and utility clients worldwide.

Via The Motley Fool

Topics Artificial Intelligence Emissions Energy

This AI-Focused Cybersecurity Company Is Down 21% in a Year, so Why Is One Fund Buying? ↗

May 21, 2026

This cybersecurity firm delivers risk assessment and vulnerability management solutions to enterprise and government clients worldwide.

Via The Motley Fool

Topics Regulatory Compliance

Oceaneering Stock Is Up 105% in a Year, and One Fund Just Disclosed a $7 Million Bet on More Growth ↗

May 21, 2026

Oceaneering International delivers subsea robotics, engineered products, and digital solutions to global energy and defense clients.

Via The Motley Fool

Topics Regulatory Compliance

Earnings Scheduled For November 6, 2025 ↗

November 06, 2025

Via Benzinga

Earnings Scheduled For August 7, 2025 ↗

August 07, 2025

Via Benzinga

Earnings Scheduled For May 8, 2025 ↗

May 08, 2025

Via Benzinga

A Look Ahead: Apyx Medical's Earnings Forecast ↗

November 07, 2024

Via Benzinga

What to Know About This Fund's $9 Million Exit From a Pawn Shop Giant Up Nearly 150% This Past Year ↗

May 21, 2026

EZCORP operates a broad network of pawn stores and digital platforms, serving consumers seeking short-term credit and value-priced goods.

Via The Motley Fool

Topics Regulatory Compliance

This Satellite Company Grew Revenue 80%. One Fund Just Disclosed Buying $6 Million Worth of Shares ↗

May 21, 2026

Satellogic delivers real-time Earth observation data and analytics, serving commercial and government clients across multiple industries.

Via The Motley Fool

Topics Regulatory Compliance

Apyx Medical (APYX) Q1 2026 Earnings Transcript ↗

May 08, 2026

Apyx Medical (APYX) Q1 2026 Earnings Transcript

Via The Motley Fool

Topics World Trade

Gapping stocks in Monday's session ↗

March 23, 2026

Via Chartmill

Navigating the Volatile Currents: AI's Enduring Grip Amidst Shifting Market Sentiments

November 20, 2025

As November 20, 2025, unfolds, global financial markets present a landscape of intriguing contrasts, marked by the persistent, transformative power of artificial intelligence and a growing undercurrent...

Via MarketMinute

Topics Artificial Intelligence ETFs Earnings

What's going on in today's after hours session ↗

November 17, 2025

As the regular session of the US market on Monday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.

Via Chartmill

APYX MEDICAL CORP (NASDAQ:APYX) Beats Q3 2025 Earnings Estimates ↗

November 06, 2025

Apyx Medical Q3 2025 earnings beat expectations with a 50% EPS surprise and strong revenue. Stock surges on successful AYON Body Contouring System launch.

Via Chartmill

Topics Earnings

APYX Medical Corp (NASDAQ:APYX) Reports Mixed Q2 2025 Earnings with Revenue Miss and Narrower Loss ↗

August 07, 2025

APYX Medical Corp reported Q2 2025 results with revenue of $11.37M, missing estimates, but a narrower EPS loss of -$0.09. Stock shows muted reaction amid commercial expansion plans.

Via Chartmill

12 Health Care Stocks Moving In Monday's After-Market Session ↗

June 23, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

May 14, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

May 13, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

May 13, 2025

Via Benzinga

APYX Stock Earnings: Apyx Medical Beats EPS, Beats Revenue for Q2 2024 ↗

August 08, 2024

APYX stock results show that Apyx Medical beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

Via InvestorPlace

Apyx Medical Corporation Announces Peer-Reviewed Clinical Publication Comparing the Use of Renuvion to a Competing Technology Following Liposuction or Body Contouring Procedures

August 08, 2024

From Apyx Medical Corporation

Via Business Wire

Earnings Scheduled For March 13, 2025 ↗

March 13, 2025

Via Benzinga

Apyx Medical Corporation Reports Second Quarter 2024 Financial Results; Updates Full Year 2024 Financial Outlook

August 08, 2024

From Apyx Medical Corporation

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.